AF
MCRB icon

Allworth Financial’s Seres Therapeutics MCRB Stock Holding History

Allworth Financial’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36 Hold
4
– – ﹤0.01% 5093
2025
Q4 		$60 Buy
+4
New +$70 ﹤0.01% 4829
2020
Q4 		– Sell
-4
Closed -$2K – 1402
2020
Q3 		$2K Buy
+4
New +$1.33K ﹤0.01% 1004

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allworth Financial's MCRB Position: Q1 2026 in Review

Allworth Financial held its Seres Therapeutics (MCRB) position steady in Q1 2026 at 4 shares worth $36. The position accounts for ﹤0.01% of the portfolio, ranked #5093.

Allworth Financial first reported a position in MCRB in Q3 2020 and has held it in 3 quarters since. The position peaked at $2K in Q3 2020. 33 funds tracked by Wall St. Rank hold MCRB as of Q1 2026.

  • Allworth Financial held 4 shares of Seres Therapeutics worth $36 as of Q1 2026.
  • Allworth Financial left its Seres Therapeutics share count unchanged in Q1 2026.
  • Seres Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5093 holding.
  • Allworth Financial first reported a position in Seres Therapeutics in Q3 2020 and has held it in 3 quarters since.
  • Allworth Financial's Seres Therapeutics position peaked at $2K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.